When a peripheral nerve is severed, the body faces a race against time. The gold standard treatment, an autograft, borrows a healthy nerve from elsewhere in the patient’s own body, but donor nerves are in short supply and the harvest site itself can be damaged. Artificial nerve guide conduits offer an alternative, yet most hollow tubes on the market today leave regenerating cells to fend for themselves in the critical first days after surgery. Now, a team of researchers in China has engineered a conduit filled with a remarkable material: a nanostructured hydrogel that does not merely sit in place but actively reshapes itself around the very cells it is meant to recruit, creating what the authors call an early regenerative microenvironment inside the implant.
The study, published in Materials Today Bio, was led by Wenbi Wu and Maling Gou and centers on a modified form of gelatin known as gelatin methacryloyl, or GelMA. Rather than using conventional GelMA, which forms a relatively static network once crosslinked, the researchers devised a way to make the material dynamic. GelMA was first self-assembled into nanodroplets dispersed within a Pluronic F68 solution, and then locked into a solid hydrogel through rapid photopolymerization under visible light. The result is a scaffold built from interconnected GelMA nanoparticles, roughly 500 to 700 nanometers across, separated by continuous micron-sized pores. Under the microscope, the network looks open and sponge-like, an architecture that supports cell infiltration and the transport of nutrients and oxygen deep within the matrix.
The key innovation lies in how the team tuned the material’s behavior. By blending GelMA with two different degrees of methacrylate substitution, one highly crosslinked at 98 percent and one lightly crosslinked at 50 percent, they produced three formulations with progressively looser networks. Rheological testing revealed that the loss modulus of these hydrogels showed pronounced frequency dependence, a signature of dynamic, rearrangeable networks. The loosest formulation, Nano-GelMA3, proved the most permissive: it had the highest porosity and swelling capacity, the lowest stiffness, and the fastest enzymatic degradation in collagenase solution. In other words, it behaved less like a rigid barrier and more like a temporary, yielding matrix that cells could push through and remodel.
Laboratory experiments demonstrated just how responsive the material is. When Schwann cells, the glial cells that act as first responders after nerve injury, were embedded in the hydrogels, they spread rapidly, proliferated vigorously, and in time-lapse imaging were seen physically deforming the surrounding nanostructure as they moved. In conventional GelMA gels, cells remained largely spherical and the matrix barely changed. In the nanostructured gels, cells and matrix engaged in a visible dialogue: the cells pulled, the network yielded, and the local architecture reorganized to accommodate them. Schwann cells seeded on the surface of a three-millimeter-thick Nano-GelMA3 block migrated through its entire depth within 72 hours, a net displacement of roughly one millimeter per day, even under a gradient of nerve growth factor mimicking the physiological cue at an injury site.
The molecular basis of this behavior points to mechanotransduction, the process by which cells convert physical cues into biochemical signals. Immunostaining showed that Schwann cells in the nanostructured gels formed far more focal adhesions, the molecular anchors connecting cells to their surroundings. Levels of paxillin, phosphorylated focal adhesion kinase, and vinculin, all core components of the adhesion machinery, were significantly elevated compared with cells in conventional gels. Quantitative PCR revealed upregulation of integrin beta, Rac1, and Cdc42, regulators of cytoskeletal dynamics and cell-matrix signaling. The cells also expressed higher levels of nerve growth factor, myelin basic protein, and myelin protein zero, suggesting a phenotype primed for supporting axons and rebuilding myelin sheaths. The authors are careful to note that these findings are associative rather than proof of a single causal signaling pathway, but the pattern is consistent with a matrix that actively coaches cells into a regenerative state.
To turn the hydrogel into an implantable device, the team built a dual-layer conduit. The inner wall is an electrospun polycaprolactone tube about 300 micrometers thick, providing tensile strength, while the outer layer is a roughly 100-micrometer F127DA hydrogel shell printed directly onto the tube by digital light processing. The resulting conduit withstood a two-newton compressive force and sprang back to its original shape, while suture retention tests confirmed it could survive surgical handling. Filled with Nano-GelMA3, the complete device, dubbed PFNC, was biocompatible with Schwann cells in extraction assays and maintained its channel structure throughout the study period.
The decisive test came in rats with ten-millimeter sciatic nerve defects. Seven days after implantation, longitudinal sections of the regenerated tissue told a striking story. In conduits filled with the adaptive hydrogel, Schwann cells had infiltrated and occupied the entire luminal matrix, forming organized cellular populations from the proximal stump deep into the conduit. In hollow control conduits, cells clustered sparsely near the proximal end, waiting for a fibrin network to form before they could advance. By 24 days, the hydrogel-filled conduits contained continuous, aligned bridges of axons and Schwann cells spanning the gap, with significantly greater NF200-positive axonal extension and bridge coverage than the hollow controls. Histology at 14 days showed regenerating neural tissue growing within the residual hydrogel, confirming that the material facilitated rather than blocked tissue ingrowth, and the loosest formulation degraded progressively in vivo, clearing space as the new tissue took over.
Twelve weeks after surgery, the functional results were remarkable. Electrophysiological recordings showed that the compound muscle action potential latency in the hydrogel-filled conduit group, at 1.32 milliseconds, was significantly better than the hollow conduit group and statistically indistinguishable from the autograft group. Nerve conduction velocity reached 36.42 meters per second, again approaching the autograft benchmark of 41 meters per second. The gastrocnemius muscles served by the repaired nerves regained wet weight and fiber diameter comparable to the autograft group, evidence that the regenerated nerves were genuinely re-innervating their targets. Under the transmission electron microscope, regenerated myelinated fibers in the hydrogel group averaged 3.79 micrometers in diameter with myelin sheaths 0.55 micrometers thick, both essentially matching the autograft values. Histological examination found no necrosis, no severe inflammatory accumulation around the implant, and no pathological abnormalities in major organs.
What distinguishes this work from earlier attempts at nerve-filling hydrogels is the mechanism of adaptation. Most dynamic hydrogels respond to cell forces through the breaking and reforming of reversible molecular crosslinks, a process that allows gradual rearrangement at the molecular scale. The Nano-GelMA system instead adapts through wholesale reorganization of its nanoparticle network, permitting rapid, large deformations that open space for migrating cells, while the interconnected pores provide room for infiltration and nutrient flow. Notably, all of this was achieved without loading the material with exogenous growth factors or drugs; the physical architecture of the matrix alone was sufficient to recruit and activate the body’s own repair cells.
The road to the clinic still has checkpoints. The authors acknowledge that scalable manufacturing, batch-to-batch quality control of nanostructure and degradation, sterilization and storage protocols, and long-term assessment of residual material clearance and fibrosis all require further work. The precise mechanotransduction pathways engaged by the matrix also await confirmation through integrin-blocking and pathway-inhibition studies. Nevertheless, the central lesson of the study is already clear: a regenerative implant does not need to be a passive scaffold. By designing materials that yield, deform, and remodel in response to the cells they host, engineers can create an environment that meets the nervous system on its own terms, and in this rat model, that meeting produced recovery on par with the body’s best self-donated tissue.
Subject of Research: A cell-adaptive nanostructured GelMA hydrogel for engineering early regenerative microenvironments in peripheral nerve repair
Article Title: A cell-adaptive nanostructured hydrogel enables an early regenerative microenvironment for peripheral nerve repair
Article References: Wu, W., Zhu, Q., Dong, Y., Zhao, W., Peng, M., Zhang, Y., Zhang, J., Liu, H., Li, L., Liu, J., Zhang, L., Ren, Y., Luo, X., Li, B., Du, T., & Gou, M. (2026). A cell-adaptive nanostructured hydrogel enables an early regenerative microenvironment for peripheral nerve repair. Materials Today Bio, 41, Article 103725. https://doi.org/10.1016/j.mtbio.2026.103725
Image Credits: AI Generated
DOI: Not provided
Keywords: peripheral nerve repair, hydrogel, GelMA, Schwann cells, nerve guidance conduit, mechanotransduction, focal adhesion, nanotechnology, tissue engineering, 3D bioprinting, nerve regeneration, biomaterials
News Source: Denise Maddox. (October 12, 2026). Living Gel That Moves With Cells Brings Damaged Nerves Back to Life. Scienmag.
